Brain Region and Isoform-Specific Phosphorylation Alters Kalirin SH2 Domain Interaction Sites and Calpain Sensitivity-Reference-Cited by-同舟云学术

Brain Region and Isoform-Specific Phosphorylation Alters Kalirin SH2 Domain Interaction Sites and Calpain Sensitivity

Published:2017-04-25 Issue:7 Volume:8 Page:1554-1569
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Miller Megan B.,Yan Yan,Machida Kazuya,Kiraly Drew D.¹,Levy Aaron D.,Wu Yi I.,Lam TuKiet T.,Abbott Thomas,Koleske Anthony J.,Eipper Betty A.,Mains Richard E.^ORCID

Affiliation:

1. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.7b00076

Reference90 articles.

1. A sequence variant in human KALRN impairs protein function and coincides with reduced cortical thickness

2. Resequencing and Association Analysis of the KALRN and EPHB1 Genes And Their Contribution to Schizophrenia Susceptibility

3. Increased expression of Kalirin-9 in the auditory cortex of schizophrenia subjects: Its role in dendritic pathology

4. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1

5. Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding cocaine-induced proteomic adaptations in the mouse nucleus accumbens;Science Signaling;2024-04-16

2. Synaptic memory and CaMKII;Physiological Reviews;2023-10-01

3. Regulated processing and secretion of a peptide precursor in cilia;Proceedings of the National Academy of Sciences;2022-07-25

4. Getting Started with the IDG KMC Datasets and Tools;Current Protocols;2022-01

5. Kalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia;CNS Drugs;2021-12-20